Page 4 - Tortious Interference News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The defendant had released a revised policy recharacterizing customized total knee replacements as experimental. (DEPOSIT PHOTOS) The maker of customized total knee replacements could bring a commercial disparagement claim against a health insurer that amended its policy statement to characterize such products as “experimental and investigational,” the 1st U.S. Circuit Court of Appeals has decided.

/PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") secured a long-awaited and much-deserved judgment against counterfeiters. After nearly four years of...

NEW YORK, Nov. 4, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") secured a long-awaited and much-deserved judgment against counterfeiters. After nearly four years of court proceedings, the Honorable Valerie E. Caproni of the United States District Court for the Southern District of New York, ordered, adjudged, and decreed that Aquavit have judgment on all counts of the Verified...

Recently, Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF) reported its financial and operating results for the second quarter, ended June 30...

Late last week, Regeneron Pharmaceuticals, Inc. filed an antitrust complaint against Amgen Inc. in the U.S. District Court for the District of Delaware.  Regeneron alleges that “Amgen...